Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Potassium permanganate 400mg tablets for cutaneous solution |
| BNF code | 1311060Q0AAACAC |
| Virtual Therapeutic Moiety | Potassium permanganate |
| Date identifier became valid | 18 Apr 2018 |
| Previous product identifier | 333343004 |
| Basis of preferred name | Other |
| Date of name applicability | 10 Feb 2009 |
| Previous name | Potassium permanganate 400mg solution tablets |
| Basis of previous name | Other |
| Reason for name change | Other |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | tablet |
| Unit dose unit of measure | tablet |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Potassium permanganate |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 400.000 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | solution.cutaneous |
| Dose Form | |
| Formulation | Tablet for cutaneous solution |
| Drug Route | |
| Route | Cutaneous |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| AnateP 400mg tablets for cutaneous solution (Essential-Healthcare Ltd) | |
| EN-Potab 400mg tablets for cutaneous solution (Ennogen Healthcare International Ltd) | |
| Permitabs 400mg tablets for cutaneous solution (Alliance Pharmaceuticals Ltd) | |
| Virtual Medicinal Product Packs | |
| Potassium permanganate 400mg tablets for cutaneous solution 30 tablet | |
dm+d data retrieved from TRUD: release NHSBSA_3.1.0_20250310000001, imported on 11th March 2025 at 03:57:45.